Coonan Clinical Labs
This article was originally published in The Tan Sheet
Executive Summary
Firm receives 510(k) marketing clearance for its blood sampling device intended for use in the company's home collection kit for HIV testing. While the device was initially submitted for clearance through "an affiliate company," Coonan maintains all marketing and ownership rights to the device, and says the 510(k) "clears the way" for the company to submit a premarket approval application for the entire home collection kit
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning